UK News Archive

2020

April

Story / Apr 24, 2020

Reflecting on 2019 – highlights from Novartis UK partnerships

Read More
Media Release / Apr 21, 2020

Novartis announces new Mayzent®▼(siponimod) data showing sustained effect in delaying disability progression for up to five years in patients with secondary progressive multiple sclerosis

Read More
Story / Apr 14, 2020

A Masterclass in Extreme Teaming: Recommendations from Professor Amy Edmondson

Read More

March

Media Release / Mar 23, 2020

Due to government instruction regarding COVID-19, we are working remotely.

Read More
Story / Mar 20, 2020

Novartis UK statement on Coronavirus (COVID-19) and our ways of working

Read More
Story / Mar 16, 2020

Novartis UK statement on Coronavirus (COVID-19) and supply chain

Read More

February

Media Release / Feb 11, 2020

UK announced as global centre of major cardiovascular trial as Novartis opens new HQ in White City, London

Read More

January

Media Release / Jan 20, 2020

Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease

Read More
Media Release / Jan 13, 2020

Novartis announces intent to collaborate with NHS England to tackle burden of cardiovascular disease in the UK

Read More
2019

November

Story / Nov 19, 2019

New and pioneering health data research hubs have the potential to transform the future of healthcare

Read More

Related Links